Voyager Therapeutics Executives Sell 33,097 Shares Amid Market Volatility

Voyager Therapeutics, Inc. (VYGR) has recently announced that Chief Scientific Officer Carter Todd Alfred sold 4,174 shares at $3.76 per share on February 24, 2026. Similarly, Chief Financial Officer Nathan D. Jorgensen sold 4,668 shares at $3.77 per share on the same day. Additionally, President and CEO Alfred Sandrock sold 14,197 shares at $3.79 per share, while COO and CBO Robin Swartz sold 6,458 shares at $3.77 per share, all on February 24, 2026.